With a vision to address growing needs for proven Turnkey e-Pedigree & Serialization Solutions, Xyntek Inc., a leading global provider of Real-Time Automated IT Systems and Microprocessor Based Industrial Automation Solutions for the Life Sciences Industries, today announced a joint and mutually exclusive strategic partnership in the U.S. with Antares Vision S.r.I., a leading provider of e-pedigree and serialization technology & solutions .
"We are proud to partner with Antares Vision to offer our clients turn-key e-pedigree and serialization solutions," says Mac Hashemian, P.E., President and CEO at Xyntek Inc. "Our strategic partnership with Antares Vision provides us the core e-pedigree & serialization technology needed to provide our Life Sciences customers turn-key serialization & e-pedigree solutions on the best and most proven technology. Antares Vision has applied its technology to the largest number of installed and operational serialization and aggregation production lines and packages with track and trace applied on a worldwide basis.”
According to Emidio Zorzella, Antares Vision CEO, "Our partnership with Xyntek is a strategic and fundamental step to improve our competitiveness in relation to major international players in a highly technological environment. After gaining the majority of European and the Turkish market, (Turkey is the first country in the world to enforce the traceability regulations) we look forward to serve the U.S. companies, partnering with a market leader such as Xyntek."
Hashemian adds, “With our joint and mutually exclusive U.S. partnership, together we will become the world’s #1 provider of turn-key e-pedigree, track & trace, serialization, brand security & protection, anti-counterfeiting, and anti-drug diversion solutions.”
Headquartered in Brescia, Italy, Antares Vision is a leader in offering technology solutions for security and Traceability/e-pedigree to the pharmaceutical industry. Its range spaces from Blister filling controls, OCR/OCV readers and verifiers, to leading edge high end controls, such as complete capsule, tablet and vials inspection machines. All products and solutions comply with GAMP5 and 21CFR part 11 directives of the FDA. Customer satisfaction, a global approach to in-line and off-line quality control, creative use of the most innovative technologies in order to supply reliable, long-lasting and user friendly solutions: these are the distinguishing features of Antares Vision and these are the benefits that will be realized through the Xyntek-Antares partnership.
Senior Vice President
301 Oxford Valley Road, Bldg. 1402-A
Yardley, PA 19067
Read the full press release featured on Yahoo! Finance